Gilead Sciences Inc GILD:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/07/21 EDT
66.50quote price arrow down-0.04 (-0.06%)
Volume
162,248
Close
66.54UNCH (UNCH)
Volume
5,611,836
52 week range
56.56 - 80.92

...

Loading . . .
  • Open66.47
  • Day High67.54
  • Day Low66.30
  • Prev Close66.54
  • 52 Week High80.92
  • 52 Week High Date05/11/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20

Key Stats

  • Market Cap83.778B
  • Shares Out1.259B
  • 10 Day Average Volume8.35M
  • Dividend2.84
  • Dividend Yield4.27%
  • Beta0.40
  • YTD % Change14.21

KEY STATS

  • Open66.47
  • Day High67.54
  • Day Low66.30
  • Prev Close66.54
  • 52 Week High80.92
  • 52 Week High Date05/11/20
  • 52 Week Low56.56
  • 52 Week Low Date12/31/20
  • Market Cap83.778B
  • Shares Out1.259B
  • 10 Day Average Volume8.35M
  • Dividend2.84
  • Dividend Yield4.27%
  • Beta0.40
  • YTD % Change14.21

RATIOS/PROFITABILITY

  • EPS (TTM)0.21
  • P/E (TTM)323.32
  • Fwd P/E (NTM)9.89
  • EBITDA (MRQ)6.294B
  • ROE (MRQ)1.47%
  • Revenue (MRQ)25.564B
  • Gross Margin (MRQ)80.58%
  • Net Margin (MRQ)1.07%
  • Debt To Equity (MRQ)159.17%

EVENTS

  • Earnings Date07/28/2021
  • Ex Div Date06/14/2021
  • Div Amount0.71
  • Split Date-
  • Split Factor-

Related Video

VIDEO1:3801:38
Gilead earnings, revenue both miss

Profile

MORE
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy...
Daniel O'Day
Chairman
Andrew Dickinson
Chief Financial Officer
Flavius Martin M.D.
Executive Vice President
Brett Pletcher
Executive Vice President
Address
333 LAKESIDE DR
Foster City, CA
94404
United States

Top Peers

SYMBOLLASTCHG%CHG
ZTS
Zoetis Inc
171.55+4.03+2.41%
AMGN
Amgen Inc
254.21+2.91+1.16%
GSK
GlaxoSmithKline PLC
38.35+0.44+1.16%
AZN
AstraZeneca PLC
53.81+0.33+0.62%
VRTX
Vertex Pharmaceuticals Inc
215.01+1.85+0.87%